Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Effects of Iron Nanoparticles Administration on Ischemia/Reperfusion Injury in Isolated Hearts of Male Wistar Rats

L. Kindernay, K. Ferenczyová, V. Farkašova, M. Barteková, I. Bernátová, T. Ravingerová

. 2023 ; 72 (Suppl 1) : S61-S72. [pub] 2023Jun09

Language English Country Czech Republic

Document type Journal Article

Iron is an essential mineral participating in numerous biological processes in the organism under physiological conditions. However, it may be also involved in the pathological mechanisms activated in various cardiovascular diseases including myocardial ischemia/reperfusion (I/R) injury, due to its involvement in reactive oxygen species (ROS) production. Furthermore, iron has been reported to participate in the mechanisms of iron-dependent cell death defined as "ferroptosis". On the other hand, iron may be also involved in the adaptive processes of ischemic preconditioning (IPC). This study aimed to elucidate whether small amounts of iron may modify the cardiac response to I/R in isolated perfused rat hearts and their protection by IPC. Pretreatment of the hearts with iron nanoparticles 15 min prior to sustained ischemia (iron preconditioning, Fe-PC) did not attenuate post-I/R contractile dysfunction. Recovery of left ventricular developed pressure (LVDP) was significantly improved only in the group with combined pretreatment with iron and IPC. Similarly, the rates of contraction and relaxation [+/-(dP/dt)max] were almost completely restored in the group preconditioned with a combination of iron and IPC but not with iron alone. In addition, the severity of reperfusion arrhythmias was reduced only in the iron+IPC group. No changes in protein levels of "survival" kinases of the RISK pathway (Reperfusion Injury Salvage Kinase) were found except for reduced caspase 3 levels in both preconditioned groups. The results indicate that a failure to precondition rat hearts with iron may be associated with the absent upregulation of RISK proteins and the pro-ferroptotic effect manifested by reduced glutathione peroxidase 4 (GPX4) levels. However, combination with IPC suppressed the negative effects of iron resulting in cardioprotection.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23013860
003      
CZ-PrNML
005      
20231006100240.0
007      
ta
008      
230907s2023 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.935112 $2 doi
035    __
$a (PubMed)37294119
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Griecsová, Lucia $u Centre of Experimental Medicine, Slovak Academy of Sciences, Institute for Heart Research, Bratislava, Slovak Republic $7 xx0248554
245    10
$a Effects of Iron Nanoparticles Administration on Ischemia/Reperfusion Injury in Isolated Hearts of Male Wistar Rats / $c L. Kindernay, K. Ferenczyová, V. Farkašova, M. Barteková, I. Bernátová, T. Ravingerová
520    9_
$a Iron is an essential mineral participating in numerous biological processes in the organism under physiological conditions. However, it may be also involved in the pathological mechanisms activated in various cardiovascular diseases including myocardial ischemia/reperfusion (I/R) injury, due to its involvement in reactive oxygen species (ROS) production. Furthermore, iron has been reported to participate in the mechanisms of iron-dependent cell death defined as "ferroptosis". On the other hand, iron may be also involved in the adaptive processes of ischemic preconditioning (IPC). This study aimed to elucidate whether small amounts of iron may modify the cardiac response to I/R in isolated perfused rat hearts and their protection by IPC. Pretreatment of the hearts with iron nanoparticles 15 min prior to sustained ischemia (iron preconditioning, Fe-PC) did not attenuate post-I/R contractile dysfunction. Recovery of left ventricular developed pressure (LVDP) was significantly improved only in the group with combined pretreatment with iron and IPC. Similarly, the rates of contraction and relaxation [+/-(dP/dt)max] were almost completely restored in the group preconditioned with a combination of iron and IPC but not with iron alone. In addition, the severity of reperfusion arrhythmias was reduced only in the iron+IPC group. No changes in protein levels of "survival" kinases of the RISK pathway (Reperfusion Injury Salvage Kinase) were found except for reduced caspase 3 levels in both preconditioned groups. The results indicate that a failure to precondition rat hearts with iron may be associated with the absent upregulation of RISK proteins and the pro-ferroptotic effect manifested by reduced glutathione peroxidase 4 (GPX4) levels. However, combination with IPC suppressed the negative effects of iron resulting in cardioprotection.
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a zvířata $7 D000818
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a potkani Wistar $7 D017208
650    _2
$a železo $x metabolismus $7 D007501
650    _2
$a srdce $7 D006321
650    12
$a reperfuzní poškození myokardu $x metabolismus $7 D015428
650    12
$a přivykání k ischémii $x metody $7 D019194
650    12
$a ischemické přivykání $7 D019157
650    _2
$a myokard $x metabolismus $7 D009206
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ferenczyová, Kristína $7 xx0307123 $u Centre of Experimental Medicine, Slovak Academy of Sciences, Institute for Heart Research, Bratislava, Slovak Republic
700    1_
$a Farkašová, Veronika, $d 1986- $7 xx0251561 $u Centre of Experimental Medicine, Slovak Academy of Sciences, Institute for Heart Research, Bratislava, Slovak Republic
700    1_
$a Barteková, Monika $7 xx0197134 $u Centre of Experimental Medicine, Slovak Academy of Sciences, Institute for Heart Research, Bratislava, Slovak Republic
700    1_
$a Bernátová, Iveta, $d 1967- $7 xx0193709 $u Centre of Experimental Medicine, Slovak Academy of Sciences, Institute of Normal and Pathological Physiology, Bratislava, Slovak Republic
700    1_
$a Ravingerová, Táňa, $d 1951- $7 xx0248557 $u Centre of Experimental Medicine, Slovak Academy of Sciences, Institute for Heart Research, Bratislava, Slovak Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, Suppl 1 (2023), s. S61-S72
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37294119 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20230907 $b ABA008
991    __
$a 20231006100234 $b ABA008
999    __
$a ok $b bmc $g 1991287 $s 1200170
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 72 $c Suppl 1 $d S61-S72 $e 2023Jun09 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK198 $a Pubmed-20230907

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...